Here Are the 3 Biggest Market Movers Monday
Here are some hot movers.

Stocks were higher on Monday, April 23, but in cautious trading as benchmark 10-year Treasury notes were near 3% for the first time in more than four years and as Wall Street prepared to enter the heart of U.S. corporate earnings season.

Benchmark 10-year notes briefly touched 3% on Monday, continuing gains made last week. On Friday, April 20, the 10-year traded as high as 2.956%, the highest level since January 2014. At last check, the yield on the 10-year Treasury was at 2.985%.

The Dow Jones Industrial Average was basically flat while the Nasdaq rose 0.2% and the S&P 500 gained 0.18%. 

Here are the 3 biggest movers, all losers, from Monday's morning trading. 

Alcoa Corp. (AA) - Alcoa shares were down 12.6% after the U.S. Treasury Department said that it could soften sanction against Russian aluminum giant Rusal if its CEO steps down. The price of aluminum dropped as a result as a new large player could soon be reentering the market. 

Cleveland-Cliffs Inc. (CLF) - shares fell 5.9% Monday afternoon after the company's first-quarter results failed to meet expectations. The company reported revenue of $239 million, yielding a net loss of 29 cents per share. Last year the company reported earnings of $1.05 per share on revenue of $6009 million. 

Skechers U.S.A. Inc. (SKX) - shares were down 4.3% after being downgraded Friday to "neutral" from "outperform" at Wedbush. The firm also cut the company's price target to $34 from $46. The company fell nearly 30% Friday after the note was first released. 

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)